Purchase Order 75N95024P00329
Award Date
6/12/24
Potential Completion Date
6/11/25
Potential Value
Not listed
Federal Agency
National Institute on Drug Abuse
Awardee
Qiagen, LLC
Ultimate Awardee
Not listed
NAICS Category
541380 - Testing Laboratories and Services
PSC Category
R499 - Support- Professional: Other
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Baltimore, MD 21224, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This $23,248.02 firm fixed-price purchase order was awarded by the Department of Health and Human Services (HHS) to Qiagen, LLC, a division of the multinational biotechnology company Qiagen N.V. The contract is not set aside. Qiagen provides sample and assay technologies, molecular diagnostics, and related products and services to support federal agencies' biomedical research, public health, law enforcement, and healthcare programs. This award is likely part of a larger indefinite delivery...
This is a $16,800 firm-fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Qiagen, LLC, a subsidiary of the multinational biotechnology company Qiagen N.V. The contract is for NIDDK to acquire 1,000 QCII Translational biospecimen samples. Qiagen provides a wide range of molecular diagnostics products, services, and instrumentation to federal agencies, including the Department of Health and Human Services, Department of Defense,...
This is a $3,156.48 firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Qiagen, LLC for the delivery of genomic DNA isolation kits. The contract is not set aside for a specific business type and was awarded on July 28, 2015 with a completion date of August 3, 2015. Qiagen, LLC is a division of the multinational biotechnology company Qiagen N.V., which provides sample and assay technologies to support federal agencies' biomedical...
This firm fixed-price purchase order was awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The $15,090 contract is for the supply of unspecified products or services, with a period of performance ending on August 27, 2018. Qiagen has previously provided a range of goods and services to federal agencies, including DNA/RNA extraction kits, sequencing equipment, bioinformatics software, and other...
This is a $33,368.50 firm fixed price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a foreign-owned for-profit manufacturer. The contract is for the provision of DNA isolation kits from November 1, 2024 to September 30, 2025. The award is not associated with a set-aside program. Qiagen has a history of providing a range of products and services to support federal agencies' biomedical research, public health, law enforcement, and healthcare...
This is a $17,029.90 firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The award does not have a set-aside designation. Qiagen provides a range of sample and assay technologies supporting federal agencies' biomedical research, public health, law enforcement, and healthcare programs. This award is associated with a larger Qiagen indefinite delivery vehicle that...
This contract was awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The contract is for preventative maintenance coverage on Qiagen's EZ2 and QIAcell laboratory equipment, with a firm fixed price of $11,517.91 and a period of performance from November 19, 2024 to November 18, 2025. Qiagen is an experienced federal contractor, having...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The $11,437.12 contract is for the purchase of QIAGEN KITS & SUPPLIES, which are likely molecular biology products and services used to support NIAID's biomedical research, public health, and healthcare programs. Qiagen is an...
This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Qiagen, LLC, a division of the multinational biotechnology company Qiagen N.V. The $7,820.97 award supports the provision of Qiagen's products and services, which include DNA/RNA extraction kits, next-generation sequencing equipment, digital PCR systems, sample preparation instruments, bioinformatics software, and precision medicine analysis tools. Qiagen has a long history...
This is a federal purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency under the Department of Health and Human Services, to Qiagen, LLC, a division of the international provider of sample and assay technologies Qiagen N.V. The contract, valued at $22,818.36, requires Qiagen to provide samples of human blood, rodent blood, and rodent brain expression for analysis by the researcher Leandro Vendruscolo. The contract is a firm fixed price purchase order with a...